KPV

A C-terminal tripeptide fragment of alpha-MSH. Retains the anti-inflammatory activity of the full peptide without melanocortin receptor binding. Research demonstrates inhibition of NF-κB pathway, reduced intestinal inflammation, and potential therapeutic application for colitis and inflammatory bowel disease. Studied in both systemic and oral/topical forms.